0
Immutep Limited has reached its limit for free report views
Work for Immutep Limited? Upgrade Your Profile and unlock all your annual reports.
Immutep Limited
- 11-50 Employees
- Based in Sydney, Australia
Immutep is a globally active biotechnology company, listed on the Australian Stock Exchange and on the NASDAQ Global Market in the US. As a leader in personalized bio-therapeutic products for cancer, Immutep is dedicated to leveraging its current technology and expertise to develop innovative treatment options for patients and maximize value to shareholders.
Immutep Limited
Most Recent Annual Report
MOST RECENT
2020 Annual Report
Report Locked. Immutep Limited has reached its limit for free report views.
